| Tag | Content |
|---|
EnhancerAtlas ID | HS193-20630 |
Organism | Homo sapiens |
Tissue/cell | U87 |
Coordinate | chr20:32142510-32143560 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxa2 | MA0047.2 | chr20:32143004-32143016 | TGTTTACATTGG | + | 6.62 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_33625 | chr20:32139423-32144536 | H2171 | | SE_62132 | chr20:32139591-32165641 | Toledo | | SE_66994 | chr20:32139423-32144536 | H2171 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH20I033553 | chr20 | 32141222 | 32144277 |
|
Enhancer Sequence | TGAGCCACTG CGCCTGGCTG TTTTTCTTTT TTAACGTTGT TTGAAAGTCT AGAATCATTT 60
TTATGTGCTA GATGAGAGAT TTGATCTGAT AAATCAAACT CAGATGTCTG CATCTCAAGT 120
GTATTTGTAG AATTATTTTT CTGTTTTCTA TTAATTTAGA TTGAATGTCA GAGTACCCAT 180
TATAGGTATT AAAATGAATA TTACATAAGA AAAAATAACA ACTTAAAAAT GTTCAGAATT 240
GTTTAAATAA AAACTTTAGA CAGACATTTA GCAGAATTTA GGTGAGCATT AAAGGATTCA 300
GGCAGCATTC AAAACTGGAA GAAGTTCAGA GAGCTCTGCT TTAGAAGCAG GCTTTTATAG 360
GCTGAACGCT GTAGCAAAGT AAAGGAATTA CTTGATTGGC TGTAGCTAGG CACTTGCCTT 420
ATTTGGATAT GATCCAGTGG AAAGTCCCTA GTTAGAGGTT TGTTTTTGAT TGGTTAAGCT 480
TAAGTTTCAT TTTATGTTTA CATTGGGCTT CAGTTTGCTT ACTAGGCACT GGAGCCAGCT 540
GTCTCAGCCT AATGGCTGCC CAATTTAAAA AAAAAAAAAC ATTAAAATGG CATGTAGTTG 600
TCATCATCAG AGTAAGAAAC CAAAGAAGAG ACCGTCATGA ATGGGATCAT TAGATCATGG 660
ACTGACACAC ATGTTCACTT AATACCCACA AGAGTGTCTT CACACTTTTT TGTCATGGAT 720
GGGACTTGTT TTCTGTTTTT TGTTTTGTTT TGTTTTTGAT ACAGTAAAAT ACTTAGGAGT 780
TCTTGCAACT TTCTATAAGT TGTTTACATT TTACTCCAAT TGCTTTATCA TTGTGTGTAT 840
TTTGGAGGTA CAGTTTTTTT CCTGAACCAC TCTGAAAGTG GAAATATGCC CTTTTATCCC 900
TAAATACTTA AATGCATATT TCCTGAAATC AAAGGCATTT TCTTACATAA CCACACATAA 960
CCACAGTACA ATTATCAAAA TCAGAAAATG TAATAATGAT ACCATACTAT TAACCTGATT 1020
CACAGACTAT ATTCAGGTTT TATAAATTAT 1050
|
